Brian Powl News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SAN DIEGO, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced the appointment of Brian Powl as Chief Commercial Officer. Mr. Powl joins Kura with more than 20 years of experience in building commercial brands in hematology and oncology, with a focus on developing and executing patient-focused strategies across sales, marketing and ma

Viewing insider transactions for Fate Therapeutics, Inc.'s ( NASDAQ:FATE ) over the last year, we see that insiders...